Registry of cataract surgery outcomes after phacoemulsification with different intraocular lenses.
Phacoemulsification and Intraocular Lens Implantation: Patient Registry
This project will collect data to see how people who have phacoemulsification do with different types of intraocular lenses.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sensor Cliniq Academic / other |
| Locations | 1 site (Warsaw) |
| Trial ID | NCT07276217 on ClinicalTrials.gov |
What this trial studies
This registry will compile retrospective and prospective clinical data on patients undergoing phacoemulsification with implantation of EDOF, monofocal-plus, or standard monofocal intraocular lenses. Retrospective data will include routinely collected preoperative, intraoperative, and postoperative information, while prospective follow-up will capture visual acuity, refraction, exam findings, patient-reported outcomes, and complications. Patients will be followed for up to 60 months after surgery to compare outcomes across lens types and time points. The registry aims to enable real-world comparisons of safety, visual performance, and patient experience associated with different IOL technologies.
Who should consider this trial
Good fit: Patients who have had or are scheduled for bilateral cataract surgery with implantation of an EDOF, monofocal-plus, or standard monofocal intraocular lens are eligible.
Not a fit: Patients with significant anterior or posterior segment disease (for example severe dry eye, corneal dystrophy, uveitis, retinal degeneration, glaucoma, or diabetic retinopathy), pseudoexfoliation, keratoconus, prior laser refractive or other ocular surgery (except cataract), amblyopia, posterior capsule opacification, postoperative BCVA < 0.5, or intraoperative complications are excluded and therefore unlikely to benefit from this registry.
Why it matters
Potential benefit: If successful, the registry could help surgeons and patients choose the intraocular lens type most likely to give better vision and fewer complications.
How similar studies have performed: Comparable registries and comparative studies of intraocular lens types have provided useful information, though long-term comparative data for newer EDOF and monofocal-plus lenses remain somewhat limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have undergone cataract surgery or are scheduled for bilateral cataract surgery with implantation of an extended-depth-of-focus (EDOF) intraocular lens, a monofocal-plus intraocular lens, or a standard monofocal intraocular lens. Exclusion Criteria: * Anterior or posterior segment pathologies affecting postoperative visual acuity, including but not limited to: severe dry eye syndrome, corneal dystrophies, uveitis, retinal degenerative changes, glaucoma, or diabetic retinopathy. * Pseudoexfoliation syndrome * Keratoconus * History of laser refractive surgery * Prior ocular surgery other than cataract surgery * Amblyopia * Posterior capsule opacification * Postoperative best-corrected visual acuity (BCVA) less 0.5 * Intraoperative complications, including posterior capsule rupture
Where this trial is running
Warsaw
- Sensor Cliniq — Warsaw, Poland (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.